Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CNMD CONMED	$52.36 -0.1%	$55.11	$46.00 ▼ $78.19	$1.62B	1.24	442,477 shs	263,473 shs
INMD InMode	$14.07 -1.0%	$14.41	$13.14 ▼ $19.85	$898.20M	1.98	1.18 million shs	1.22 million shs
LIVN LivaNova	$45.80 -0.2%	$42.47	$32.48 ▼ $57.35	$2.50B	0.9	635,400 shs	308,949 shs
MASI Masimo	$166.71 -1.5%	$160.11	$101.61 ▼ $194.88	$9.18B	1.19	638,509 shs	590,110 shs

7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CNMD CONMED	-0.01%	+0.67%	-9.55%	-11.03%	-22.52%
INMD InMode	-0.99%	+5.47%	-3.23%	-20.51%	-18.72%
LIVN LivaNova	-0.15%	+1.39%	+4.04%	+17.05%	-15.92%
MASI Masimo	-1.53%	+2.42%	+6.02%	+1.93%	+26.43%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CNMD CONMED	4.4092 of 5 stars	2.1	2.0	2.5	4.3	2.2	0.8	3.1
INMD InMode	3.5386 of 5 stars	4.1	3.0	0.0	0.0	1.4	1.7	1.9
LIVN LivaNova	3.2751 of 5 stars	3.5	4.0	0.0	0.0	2.3	1.7	1.3
MASI Masimo	4.1505 of 5 stars	3.4	1.0	0.0	4.2	2.2	2.5	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CNMD CONMED	2.20	Hold	$62.20	18.79% Upside
INMD InMode	2.13	Hold	$18.54	31.78% Upside
LIVN LivaNova	3.00	Buy	$59.29	29.44% Upside
MASI Masimo	2.83	Moderate Buy	$191.60	14.93% Upside

Current Analyst Ratings Breakdown

Latest MASI, INMD, LIVN, and CNMD Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/12/2025	CNMD CONMED	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold	$61.00
5/20/2025	LIVN LivaNova	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Peer Perform ➝ Outperform	$60.00
5/13/2025	LIVN LivaNova	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$64.00 ➝ $64.00
5/8/2025	LIVN LivaNova	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$56.00 ➝ $55.00
5/8/2025	LIVN LivaNova	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$55.00 ➝ $61.00
5/7/2025	MASI Masimo	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$193.00
5/7/2025	MASI Masimo	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$215.00 ➝ $200.00
5/7/2025	MASI Masimo	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$204.00 ➝ $185.00
5/7/2025	MASI Masimo	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$205.00 ➝ $190.00
5/1/2025	CNMD CONMED	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$70.00 ➝ $58.00
5/1/2025	CNMD CONMED	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$70.00 ➝ $57.00

(Data available from 6/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CNMD CONMED	$1.31B	1.24	$6.71 per share	7.80	$31.16 per share	1.68
INMD InMode	$394.82M	2.25	$1.81 per share	7.79	$10.12 per share	1.39
LIVN LivaNova	$1.25B	1.99	$4.23 per share	10.82	$24.31 per share	1.88
MASI Masimo	$2.09B	4.32	$6.29 per share	26.50	$19.50 per share	8.55

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CNMD CONMED	$132.42M	$3.80	13.78	10.33	1.35	9.02%	14.36%	5.86%	7/30/2025 (Estimated)
INMD InMode	$181.27M	$2.33	6.04	7.73	N/A	44.79%	17.17%	15.20%	7/30/2025 (Estimated)
LIVN LivaNova	$63.23M	-$4.09	N/A	14.59	N/A	-17.41%	13.67%	6.68%	7/30/2025 (Estimated)
MASI Masimo	-$304.90M	-$9.17	N/A	36.01	N/A	-25.06%	22.56%	10.00%	8/5/2025 (Estimated)

Latest MASI, INMD, LIVN, and CNMD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/6/2025	Q1 2025	MASI Masimo	$1.24	$1.36	+$0.12	-$3.12	$367.79 million	$372.00 million
4/30/2025	Q1 2025	CNMD CONMED	$0.81	$0.95	+$0.14	$0.19	$313.38 million	$321.26 million
4/28/2025	Q1 2025	INMD InMode	$0.45	$0.31	-$0.14	$0.26	$82.21 million	$77.87 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CNMD CONMED	$0.80	1.53%	N/A	21.05%	N/A
INMD InMode	N/A	N/A	N/A	N/A	N/A
LIVN LivaNova	N/A	N/A	N/A	N/A	N/A
MASI Masimo	N/A	N/A	N/A	N/A	N/A

Latest MASI, INMD, LIVN, and CNMD Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/21/2025	CNMD CONMED	quarterly	$0.20	1.34%	6/13/2025	6/13/2025	7/3/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CNMD CONMED	0.91	2.26	1.00
INMD InMode	N/A	8.73	7.86
LIVN LivaNova	0.53	1.58	1.37
MASI Masimo	0.67	2.17	1.62

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CNMD CONMED	N/A
INMD InMode	68.04%
LIVN LivaNova	97.64%
MASI Masimo	85.96%

Insider Ownership

Company	Insider Ownership
CNMD CONMED	3.10%
INMD InMode	6.92%
LIVN LivaNova	0.29%
MASI Masimo	9.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CNMD CONMED	3,900	30.94 million	29.98 million	Optionable
INMD InMode	480	63.21 million	58.84 million	Optionable
LIVN LivaNova	2,900	54.53 million	54.37 million	Optionable
MASI Masimo	5,600	54.22 million	48.96 million	Optionable

MASI, INMD, LIVN, and CNMD Headlines

Recent News About These Companies

MASIMO CORPORATION INVESTIGATION ALERT: Johnson Fistel, PLLP Investigates Potential Breach of Fiduciary Duties by Masimo Officers and Directors

1 hour ago | globenewswire.com

Masimo (NASDAQ:MASI) Updates FY 2025 Earnings Guidance

June 25 at 7:11 AM | marketbeat.com

Wealthquest Corp Invests $352,000 in Masimo Corporation (NASDAQ:MASI)

June 25 at 6:46 AM | marketbeat.com

Masimo Corporation (NASDAQ:MASI) Given Consensus Recommendation of "Moderate Buy" by Brokerages

June 25 at 2:19 AM | marketbeat.com

Masimo Corporation: A Much Cleaner Picture

June 23, 2025 | seekingalpha.com

Exchange Traded Concepts LLC Has $590,000 Stock Holdings in Masimo Corporation (NASDAQ:MASI)

June 22, 2025 | marketbeat.com

Silver Oak Securities Incorporated Invests $268,000 in Masimo Corporation (NASDAQ:MASI)

June 21, 2025 | marketbeat.com

Why The Apple Watch Is Losing Its Blood Oxygen Sensor

June 19, 2025 | msn.com

Masimo Corporation (NASDAQ:MASI) Position Lowered by Assenagon Asset Management S.A.

June 19, 2025 | marketbeat.com

Masimo Fails to Disqualify Law Firm From Ousted Founder’s Team

June 17, 2025 | news.bloomberglaw.comN

Study finds Masimo’s SedLine brain function monitoring shows advantages during pediatric anesthesia

June 14, 2025 | pharmabiz.comP

Masimo COO Departs Amid Leadership Shakeup

June 14, 2025 | marketwatch.com

Masimo COO to Resign

June 14, 2025 | ocbj.comO

Masimo Announces Key Leadership Changes in June 2025

June 12, 2025 | tipranks.com

Here's How Much You Would Have Made Owning Masimo Stock In The Last 10 Years

June 12, 2025 | benzinga.com

MASI INVESTIGATION ALERT: Johnson Fistel PLLP Investigates the Directors and Officers of Masimo Corporation for Breach of Fiduciary Duties

June 10, 2025 | globenewswire.com

New Study Finds Masimo SedLine® Brain Function Monitoring Offers Significant Advantages During Pediatric Anesthesia

June 10, 2025 | finance.yahoo.com

Research: Masimo SedLine Enhances Pediatric Anesthesia

June 10, 2025 | miragenews.comM

New Masimo CEO Katie Szyman Reveals Personal Ties to Device Maker

June 10, 2025 | ocbj.comO

Study backs Masimo brain monitoring tech during pediatric anesthesia

June 10, 2025 | massdevice.com

3 Reasons MASI is Risky and 1 Stock to Buy Instead

June 9, 2025 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

MASI, INMD, LIVN, and CNMD Company Descriptions

CONMED NYSE:CNMD

$52.36 -0.05 (-0.09%)

Closing price 06/26/2025 03:59 PM Eastern

Extended Trading

$52.34 -0.02 (-0.04%)

As of 06/26/2025 05:11 PM Eastern

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

InMode NASDAQ:INMD

$14.07 -0.14 (-0.99%)

Closing price 06/26/2025 04:00 PM Eastern

Extended Trading

$14.16 +0.09 (+0.64%)

As of 08:03 AM Eastern

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

LivaNova NASDAQ:LIVN

$45.80 -0.07 (-0.15%)

Closing price 06/26/2025 04:00 PM Eastern

Extended Trading

$45.69 -0.11 (-0.24%)

As of 06:38 AM Eastern

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

Masimo NASDAQ:MASI

$166.71 -2.59 (-1.53%)

Closing price 06/26/2025 04:00 PM Eastern

Extended Trading

$166.75 +0.04 (+0.02%)

As of 07:59 AM Eastern

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time